Insights
Stock Story: Thermo Fisher Scientific
Dr Deborah Lambie, 06 Aug 2020
Thermo Fisher Scientific is a company at the centre of the fight against COVID-19. Global Equities Analyst Dr Deborah Lambie…
Vaccine Time: The Beginning of the Pandemic’s End
Marissa Rossi, 05 Aug 2020
In total, there are 177 novel coronavirus vaccines in development globally and 6 in Phase III trials, the final stage…
Investing in infrastructure – the case for airports
Daniel Simmonds, 30 Jul 2020
We’re going to focus on the global aviation sector and aim to offer some insights into how COVID-19 has impacted…
A stock picker’s market
Michael Higgins, 09 Jul 2020
Market volatility creates significant opportunities for active investors like Milford, who invest in specific companies rather than simply investing in…
Melbourne Lockdown Take Two
William Curtayne, 08 Jul 2020
Faced with two bad choices, Victorian Premier Daniel Andrews has made the difficult decision to lockdown metropolitan Melbourne for six…
Stock Story: Saracen Minerals
Greg Cassidy, 06 Jul 2020
Senior Analyst Greg Cassidy shares the story behind the success of Saracen Minerals and how our investment in the company…
Health Care: A hunting ground for investment opportunities in uncertain times
Alexander Whight, 01 Jul 2020
It is hard to believe just 3 months have passed since the market lows of late-March. Equity markets have moved…
Victoria shuts down hotspot suburbs – what does it mean for the market?
William Curtayne, 01 Jul 2020
From midnight Wednesday in Melbourne, 36 suburbs in 10 postcodes will be placed in lockdown. Residents in those suburbs will…